Astria Therapeutics, Inc. (ATXS)

NASDAQ: ATXS · Real-Time Price · USD

13.20

+0.27 (2.09%)

At close: Jan 7, 2026, 4:00 PM EST

13.29

+0.09 (0.68%)

After-hours: Jan 7, 2026, 7:59 PM EST

Astria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '26 Jan 7, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	754	505	279	389	70	43	Upgrade
Market Cap Growth	42.66%	80.99%	-28.37%	454.95%	63.15%	-38.35%	Upgrade
Enterprise Value	531	261	186	370	35	-9	Upgrade
Last Close Price	12.93	8.94	7.68	14.89	5.39	12.84	Upgrade
PS Ratio	1067.71	-	-	-	-	-	Upgrade
PB Ratio	5.29	1.58	1.15	1.76	0.57	1.06	Upgrade
P/TBV Ratio	5.47	2.25	1.89	3.12	2.71	1.06	Upgrade
EV/Sales Ratio	751.48	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.02	0.02	0.00	0.00	0.00	0.03	Upgrade
Asset Turnover	0.00	-	-	-	-	-	Upgrade
Quick Ratio	10.42	17.15	21.35	24.99	24.12	7.03	Upgrade
Current Ratio	10.78	17.49	21.73	25.13	24.42	7.25	Upgrade
Return on Equity (ROE)	-43.15%	-33.52%	-31.40%	-30.18%	-239.18%	-97.66%	Upgrade
Return on Assets (ROA)	-26.93%	-23.36%	-17.47%	-18.67%	-21.69%	-52.44%	Upgrade
Return on Capital (ROIC)	-29.17%	-24.55%	-18.21%	-19.39%	-23.08%	-58.72%	Upgrade
Return on Capital Employed (ROCE)	-55.00%	-34.50%	-27.90%	-24.10%	-24.80%	-91.20%	Upgrade
Earnings Yield	-16.45%	-18.68%	-26.15%	-13.32%	-277.97%	-86.78%	Upgrade
FCF Yield	-15.96%	-16.16%	-24.56%	-11.21%	-43.03%	-75.66%	Upgrade
Buyback Yield / Dilution	-14.24%	-86.44%	-106.03%	-63.81%	-191.81%	-63.87%	Upgrade

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q